Top Markets
Coin of the day
Altamira Therapeutics Ltd. Altamira Therapeutics Ltd.

Altamira Therapeutics Ltd.

CYTO
Clasificación en acciones #38206
Altamira Therapeutics Ltd. is a biotechnology firm dedicated to pioneering new... Altamira Therapeutics Ltd. is a biotechnology firm dedicated to pioneering new treatments for critical medical needs that are currently underserved. Its marketed offerings include Bentrio, a non-pharmaceutical nasal spray designed for individual protection against prevalent airborne viruses and allergens. The company is also heavily invested in developing RNA therapeutics specifically for extrahepatic targets. This includes their preclinical OligoPhore and SemaPhore platforms, engineered for the effective delivery of oligonucleotides and mRNA. In its clinical-stage portfolio, AM-125 is undergoing Phase II trials for the intranasal treatment of vertigo. Additionally, Keyzilen and Sonsuvi are both in Phase III clinical development; Keyzilen is focused on acute inner ear tinnitus, and Sonsuvi addresses acute inner ear hearing loss. Established in 2003 and headquartered in Hamilton, Bermuda, Altamira Therapeutics conducts operations across Switzerland, the United States, Europe, and Australia. The company officially adopted the name Altamira Therapeutics Ltd. in July 2021, prior to which it was known as Auris Medical Holding Ltd.
Precio por acción
$0.3
Última sincronización: 2026-02-10
Capitalización bursátil
$1.13M
Cambio (1 día)
0.00%
Cambio (1 año)
328.57%
País
BM
Comercio Altamira Therapeutics Ltd. (CYTO)

Categoría

Historial del precio de la acción de Altamira Therapeutics Ltd. (CYTO)
Precio más alto de cierre: $0.30 el 2026-02-01

Precio más bajo de cierre: $502.51K el 2014-08-01
Historial del precio de la acción de Altamira Therapeutics Ltd. desde 2014 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 0.00%
2025 -8.12%
2024 -93.34%
2023 -95.12%
2022 -83.04%
2021 -50.21%
2020 106.19%
2019 -84.04%
2018 -90.18%
2017 -62.31%
2016 -66.97%
2015 -7.95%
2014 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$505.24 29.45%
US
$846.09 29.68%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE